Dr. Nivedita Sarkar

Dr Nivedita Sarkar is radiation oncologist with a total of 7 years of experience in the specialty. She has trained at the prestigious KIDWAI Cancer Institute, Bangalore where she learned the basics of radiation therapy. During her post-graduation, she got to learn various techniques of radiotherapy like 3DCRT, IMRT and VMAT. She also had the opportunity to train briefly to learn about Cyberknife and Tomotherapy at HCG Hospital, Bangalore. She got exposure to research-oriented activities which helped her gain knowledge as well as confidence not only at the national level but also at international platforms. Then she went ahead to finish my DNB in Radiation Oncology, again from an elite institute of Sri Shankara Cancer Hospital, Bangalore. Here she further learnt about higher-end techniques including a vast knowledge of brachytherapy which consolidated her strong base. Later she moved to Delhi NCR where she worked at Narayana Health, Gurugram which helped her fine-tune her learning. Later she completed a year of fellowship at Tata Medical Center, Kolkata. Here she gained knowledge and experience about the advanced techniques like SRS and SBRT as well as clinical oncology.

• Brachytherapy

• Best Oral Paper Presentation and Gold Medal 2016, International Cancer Congress, Nagpur 
• Dr M S Gujral Gold Medal 2017, Indian Cancer Congress, Bangalore 
• ESMO ASIA Travel Grant recipient, 2017, Singapore
• Part of ADD ASPIRIN trial (A phase III, double-blind, placebo-controlled randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours) under the aegis of MRC UK as a delegated co-investigator from January 2022 to February 2023.
• Part of PRIME trial (Randomised controlled trial of Prostate Radiotherapy In high risk and node positive disease comparing Moderate and Extreme hypofractionation) in collaboration with TMH, Mumbai from January 2022 to February 2023.
• Part of HYPORT adjuvant trial (Hypofractionated radiation therapy comparing a standard radiotherapy schedule over three weeks with a novel one week schedule in adjuvant breast cancer - an open label randomised controlled trial) a multi-institutional study led by TMC, Kolkata from January 2022 to February 2023.
• Part of Audit of outcomes in oral carcinoma at Tata Medical Centre, Kolkata leading to an outcome prediction model from January 2022 to February 2023

Brachytherapy experience:

• Performed intracavitary, interstitial and vaginal brachytherapy for gynaecological cancers independently at KIDWAI and Sri Shankara Cancer Hospital.
• Performed head and neck cancer as well as breast cancer interstitial brachytherapy independently at Sri Shankara Cancer Hospital.
• Assisted in prostate brachytherapy and hepatobiliary brachytherapy at Sri Shankara Cancer Hospital.
• Assisted in IORT breast brachytherapy at Narayana Health City, Bangalore.